Molecular Mechanisms of Malignant Cerebral Edema After LHI
NCT ID: NCT03703284
Last Updated: 2020-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2018-01-01
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Etiology and Prognostic Risk Factors of Intracerebral Hemorrhage in Beijing
NCT02350010
Early Identification of Malignant Brain Edema in laRge Artery oCclusive Stroke After Endovascular Therapy (EMBRACE Study)
NCT06451887
Early Prophylactic Decompressive Hemicraniectomy Following Endovascular Therapy in Large Hemispheric Infarct Trial
NCT07118345
Early Neurological Trajectory and Clinical Outcomes in Brain Acute Ischemic Stroke
NCT06170086
Automatic PredICtion of Edema After Stroke
NCT04057690
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LHI Hernia
Acute (\<=48h) large hemispheric infarction (LHI) patients who developed cerebral hernia in 5 days post-stroke
Treatments to reduce intracranial pressure
Drugs such as mannitol, glycerin fructose, etc and/or surgery
LHI Non-Hernia
Acute (\<=48h) large hemispheric infarction (LHI) patients without cerebral hernia in 5 days post-stroke
Treatments to reduce intracranial pressure
Drugs such as mannitol, glycerin fructose, etc and/or surgery
Healthy control
Healthy individuals
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treatments to reduce intracranial pressure
Drugs such as mannitol, glycerin fructose, etc and/or surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\. Clinical diagnosis of large hemispheric infarction
* 3\. Within 48h after stroke onset.
Exclusion Criteria
* 2\. Clinical diagnosis of severe heart, liver or kidney diseases;
* 3\. Clinical diagnosis of bleeding tendency, active bleeding or hematological diseases;
* 4\. Malignant tumor;
* 5\. Modified Rankin Scale (mRS)\<2 before stroke onset.
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xuanwu Hospital, Beijing
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yan Zhang
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yan Zhang, M.D., PhD
Role: PRINCIPAL_INVESTIGATOR
Xuanwu Hospital of Capital Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xuanwu Hospital of Capital Medical University
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LHI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.